Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Acquisitions & Divestments: 2018-2024

Historic Change in Acquisitions & Divestments for Kiniksa Pharmaceuticals International (KNSA) over the last 7 years, with Dec 2024 value amounting to $239.9 million.

  • Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments rose 74.67% to $84.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.2 million, marking a year-over-year increase of 24.06%. This contributed to the annual value of $239.9 million for FY2024, which is 36.71% up from last year.
  • According to the latest figures from FY2024, Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments is $239.9 million, which was up 36.71% from $175.5 million recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments ranged from a high of $407.1 million in FY2020 and a low of $127.8 million during FY2022.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Change in Acquisitions & Divestments value was $175.5 million (recorded in 2023), while the average stood at $181.1 million.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments crashed by 58.28% in 2022 and then surged by 37.33% in 2023.
  • MRY analysis of 5 years shows Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments stood at $407.1 million in 2020, then fell by 24.75% to $306.3 million in 2021, then tumbled by 58.28% to $127.8 million in 2022, then soared by 37.33% to $175.5 million in 2023, then surged by 36.71% to $239.9 million in 2024.
  • Its Change in Acquisitions & Divestments was $239.9 million in FY2024, compared to $175.5 million in FY2023 and $127.8 million in FY2022.